Aenitis Technologies
PrivateLast Round
VC Round
Oct 10, 2024
Total Funding Raised
$10.44M
Company Overview
Aenitis Technologies operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a VC Round in October 2024.
Aenitis Technologies is a biotechnology company that develops and markets acoustofluidic technology for contact-free cell handling, sorting, and filtration to make cell and gene therapy manufacturing safer and less expensive.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aenitis Technologies Comparables
Compare Aenitis Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascent Bio-Nano Technologies | 83% | |
| AcouSort AB | 82% | |
| LevitasBio | 77% |
For institutional investors. Book with your work email.
Aenitis Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 10, 2024 | ||||
| Grant | Dec 10, 2019 | ||||
| Grant | Dec 11, 2018 | ||||
| Series A | Aug 19, 2018 | ||||
| Grant | Nov 30, 2017 | ||||
Seed | Oct 19, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aenitis Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stamos Capital Partners | VC Round |
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | VC Round |
| Weaving Invest | VC Round |
| European Commission | Grant |
| Bpifrance | Grant |
| Seventure Partners | Seed, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Signed a Memorandum of Understanding (MOU) with the global pharmaceutical company.
- Oct 10, 2024
$7M round led by European Innovation Council and Seventure Partners.
For institutional investors. Book with your work email.
Aenitis Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aenitis Technologies's valuation, stock price, and market status.
Is Aenitis Technologies a public or private company?
Aenitis Technologies is a private company.
What is the current stock price of Aenitis Technologies?
Aenitis Technologies is a private company, so its shares have no public market price. Caplight tracks Aenitis Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aenitis Technologies worth (valuation)?
Valuation information for Aenitis Technologies is not publicly available.
Can I buy Aenitis Technologies stock?
Aenitis Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aenitis Technologies's last funding round?
Aenitis Technologies's most recent funding round was VC Round on October 10, 2024.
Who are the main investors in Aenitis Technologies?
Key investors in Aenitis Technologies include European Innovation Council Fund, Seventure Partners.
Will Aenitis Technologies IPO soon?
No public IPO plans have been announced for Aenitis Technologies.
How can I track Aenitis Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Aenitis Technologies's shares on secondary markets.